, Volume 61, Issue 10, pp 1531–1531 | Cite as

Hypertension in Diabetes Mellitus: Role of β-Blockers

  • Franz H. Messerli
  • Ehud Grossman


Diabetes Mellitus Myocardial Infarction Coronary Heart Disease Acute Myocardial Infarction Erectile Dysfunction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Dunne F, Kendall MJ, Marin U. β-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role? Drugs 2001; 61: 429–35PubMedCrossRefGoogle Scholar
  2. 2.
    Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304: 405–12CrossRefGoogle Scholar
  3. 3.
    Messerli FH, Grossman E, Goldbourt U. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? JAMA 1998; 279: 1903–7PubMedCrossRefGoogle Scholar
  4. 4.
    UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317: 703–13CrossRefGoogle Scholar
  5. 5.
    Sharma AM, Pischon T, Hardt S, et al. Hypothesis: β-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension 2001; 37: 250–4PubMedCrossRefGoogle Scholar
  6. 6.
    Gress TW, Nieto PJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus: atherosclerosis risk in communities study. N Engl J Med 2000; 342: 905–12PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2001

Authors and Affiliations

  • Franz H. Messerli
    • 1
  • Ehud Grossman
    • 2
  1. 1.Department of Internal Medicine Section on HypertensionOchsner Clinic and Alton Ochsner Medical FoundationNew OrleansUSA
  2. 2.Internal Medicine DThe Chaim Sheba Medical CenterTel-HashomerIsrael

Personalised recommendations